Phase I/ II trial of chemoradiotherapy with concurrent S‐1 and cisplatin for clinical stage II / III esophageal carcinoma ( JCOG 0604)-Reference-Cited by-同舟云学术

Phase I/ II trial of chemoradiotherapy with concurrent S‐1 and cisplatin for clinical stage II / III esophageal carcinoma ( JCOG 0604)

Published:2015-09-21 Issue:10 Volume:106 Page:1414-1420
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Tahara Makoto¹²,Fuse Nozomu²,Mizusawa Junki³,Sato Akihiro⁴,Nihei Keiji⁵,Kanato Keisuke⁶,Kato Ken⁷,Yamazaki Kentaro⁸,Muro Kei⁹,Takaishi Hiromasa¹⁰,Boku Narikazu⁷,Ohtsu Atsushi²⁴

Affiliation:

1. Department of Head and Neck Medical Oncology National Cancer Center Hospital East Kashiwa Japan

2. Department of Gastrointestinal Oncology National Cancer Center Hospital East KashiwaJapan

3. Japan Clinical Oncology Group Data Center National Cancer Center TokyoJapan

4. Exploratory Oncology Research and Clinical Trial Center National Cancer Center KashiwaJapan

5. Department of Radiology Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital TokyoJapan

6. Japan Clinical Oncology Group Operations Office National Cancer Center TokyoJapan

7. Department of Gastrointestinal Medical Oncology National Cancer Center Hospital TokyoJapan

8. Division of Gastrointestinal Oncology Shizuoka Cancer Center ShizuokaJapan

9. Department of Clinical Oncology Aichi Cancer Center Hospital NagoyaJapan

10. Keio Cancer Center Keio University Hospital Tokyo Japan

Funder

Ministry of Health, Labor and Welfare

Ministry of Health, Labor and Welfare for the Third Term Comprehensive Strategy for Cancer Control

Grant-in-Aid for Cancer Research

National Cancer Center Research and Development Fund

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.12764

Reference21 articles.

1. A Randomized Trial Comparing Postoperative Adjuvant Chemotherapy with Cisplatin and 5-Fluorouracil Versus Preoperative Chemotherapy for Localized Advanced Squamous Cell Carcinoma of the Thoracic Esophagus (JCOG9907)

2. INT 0123 (Radiation Therapy Oncology Group 94-05) Phase III Trial of Combined-Modality Therapy for Esophageal Cancer: High-Dose Versus Standard-Dose Radiation Therapy

3. Antitumor activity of 1 M tegafur‐0.4 M 5‐chloro‐2,4‐dihydroxypyridine‐1 M potassium oxonate (S‐1) against human colon carcinoma orthotopically implanted into nude rats;Shirasaka T;Cancer Res,1996

4. 1187 PUBLICATION Combined therapy with radiation and S-1, an oral new 5-FU prodrug, is markedly effective against non-small cell lung cancer xenografts in mice

5. Gimeracil, a component of S-1, may enhance the antitumor activity of X-ray irradiation in human cancer xenograft models in vivo

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of surgery or definitive chemoradiotherapy in management of localized squamous cell carcinoma of esophagus – What is the verdict?;Critical Reviews in Oncology/Hematology;2023-10

2. Definitive S-1/mitomycin-C chemoradiotherapy for stage II/III anal canal squamous cell carcinoma: a phase I/II dose-finding and single-arm confirmatory study (JCOG0903);International Journal of Clinical Oncology;2023-06-07

3. Analysis of particle therapy registries based on a unified treatment policy for esophageal cancer;Journal of Radiation Research;2023-04-07

4. A Transcriptomic Liquid Biopsy Assay for Predicting Resistance to Neoadjuvant Therapy in Esophageal Squamous Cell Carcinoma;Annals of Surgery;2022-05-12

5. Pretreatment Low Serum Sodium as a Prognostic Factor for Patients with Esophageal Cancer Treated with Radiotherapy or Chemoradiotherapy;Journal of Oncology;2022-03-21